Camingao, Jora Mae P.
HRN: 29-02-18 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CO-AMOXICLAV 625MG (TAB)
05/18/2026
05/25/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; UTI
Checking Initial Appropriateness